Sieswerda, E;
Boer, M.G.J. de;
Bonten, M. M. J;
Boersma, W. G;
Jonkers, R. E;
Aleva, R. M;
Kullberg, B. J;
Schouten, J. A;
van de Garde, E.M. W;
Verheij, T. J;
van der Eerden, M. M;
Prins, J. M;
Wiersinga, W. J.
The Dutch Working Party on Antibiotic Policy constituted a multidisciplinary expert committee to provide evidence-based recommendation for the use of antibacterial therapy in hospitalized adults with a respiratory infection and suspected or proven 2019 Coronavirus disease (COVID-19). We performed a liter...
Jin, Ying-Hui;
Zhan, Qing-Yuan;
Peng, Zhi-Yong;
Ren, Xue-Qun;
Yin, Xun-Tao;
Cai, Lin;
Yuan, Yu-Feng;
Yue, Ji-Rong;
Zhang, Xiao-Chun;
Yang, Qi-Wen;
Ji, Jianguang;
Xia, Jian;
Li, Yi-Rong;
Zhou, Fu-Xiang;
Gao, Ya-Dong;
Yu, Zhui;
Xu, Feng;
Tu, Ming-Li;
Tan, Li-Ming;
Yang, Min;
Chen, Fang;
Zhang, Xiao-Ju;
Zeng, Mei;
Zhu, Yu;
Liu, Xin-Can;
Yang, Jian;
Zhao, Dong-Chi;
Ding, Yu-Feng;
Hou, Ning;
Wang, Fu-Bing;
Chen, Hao;
Zhang, Yong-Gang;
Li, Wei;
Chen, Wen;
Shi, Yue-Xian;
Yang, Xiu-Zhi;
Wang, Xue-Jun;
Zhong, Yan-Jun;
Zhao, Ming-Juan;
Li, Bing-Hui;
Ma, Lin-Lu;
Zi, Hao;
Wang, Na;
Wang, Yun-Yun;
Yu, Shao-Fu;
Li, Lu-Yao;
Huang, Qiao;
Weng, Hong;
Ren, Xiang-Ying;
Luo, Li-Sha;
Fan, Man-Ru;
Huang, Di;
Xue, Hong-Yang;
Yu, Lin-Xin;
Gao, Jin-Ping;
Deng, Tong;
Zeng, Xian-Tao;
Li, Hong-Jun;
Cheng, Zhen-Shun;
Yao, Xiaomei;
Wang, Xing-Huan.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Chemoprevention/methods,
Coronavirus Infections/diagnosis,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/diagnosis,
Pneumonia, Viral/drug therapy,
Pandemics/prevention & control,
Betacoronavirus/drug effects,
Evidence-Based Practice/methods,
Anti-Retroviral Agents/therapeutic use,
Lopinavir/therapeutic use,
Chloroquine/therapeutic use,
Receptors, Interleukin-6/therapeutic use,
Hydroxychloroquine/therapeutic use,
Plasma/immunology
Rochwerg, Bram;
Agarwal, Arnav;
Zeng, Linan;
Leo, Yee-Sin;
Appiah, John Adabie;
Agoritsas, Thomas;
Bartoszko, Jessica;
Brignardello-Petersen, Romina;
Ergan, Begum;
Ge, Long;
Geduld, Heike;
Gershengorn, Hayley B;
Manai, Hela;
Huang, Minhua;
Lamontagne, François;
Kanda, Seema;
Kawano-Dourado, Leticia;
Kurian, Linda;
Kwizera, Arthur;
Murthy, Srinivas;
Qadir, Nida;
Siemieniuk, Reed;
Silvestre, Maria Asuncion;
Vandvik, Per Olav;
Ye, Zhikang;
Zeraatkar, Dena;
Guyatt, Gordon.
Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...
A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/pathogenicity,
Coronavirus Infections/diagnostic imaging,
Coronavirus Infections/complications,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/diagnostic imaging,
Pneumonia, Viral/drug therapy,
Pneumonia, Viral/complications,
Pandemics/statistics & numerical data,
Symptom Flare Up,
Risk Groups,
China/epidemiology,
Healthcare-Associated Pneumonia/diagnosis,
Health Personnel/organization & administration,
Carrier State/transmission,
Infectious Disease Transmission, Vertical/prevention & control
The COVID-19 pandemic requires to conscientiously weigh ‘‘timely surgical intervention’’ for colorectal cancer against efforts to conserve hospital resources and protect patients and health care providers. Professional societies provided ad-hoc guidance at the outset of the COVID-19 pandemic on d...
Since its identification in China in December 2019, the novel coronavirus COVID-19 has rapidly evolved into a pandemic. COVID-19 manifests with non-specific respiratory symptoms of variable severity and may require advanced respiratory support. The diagnosis of COVID-19 is currently confirmed by laborato...
Falavigna, Maicon;
Colpani, Verônica;
Stein, Cinara;
Azevedo, Luciano César Pontes;
Bagattini, Ângela Maria;
Brito, Gabriela Vilela de;
Chatkin, José Miguel;
Cimerman, Sérgio;
Corradi, Mirian de Freitas Dal Ben;
Cunha, Clóvis Arns da;
Medeiros, Flávia Cordeiro de;
Oliveira Júnior, Haliton Alves de;
Fritscher , Leandro Genehr;
Gazzana, Marcelo Basso;
Graf, Débora Dalmas;
Marra, Lays Pires;
Matuoka , Jéssica Yumi;
Nunes, Michelle Silva;
Pachito, Daniela Vianna;
Pagano, Cássia Garcia Moraes;
Parreira, Patrícia do Carmo Silva;
Riera, Rachel;
Silva Júnior, Amilton;
Tavares, Bruno de Melo;
Zavascki, Alexandre Prehn;
Rosa, Régis Goulart;
Dal-Pizzol, Felipe.
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Coronavirus Infections/drug therapy,
Aminoquinolines/therapeutic use,
Oseltamivir/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Heparin/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Betacoronavirus/drug effects,
Pneumonia, Viral/drug therapy,
Pandemics/prevention & control
China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries
...
Betacoronavirus/drug effects,
Pneumonia, Viral/epidemiology,
Coronavirus Infections/epidemiology,
China/epidemiology,
Pandemics/prevention & control,
Pandemics/statistics & numerical data,
Epidemiological Monitoring,
Health Information Management/methods,
Interferons/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Ribavirin/therapeutic use,
Chloroquine/therapeutic use,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy
The purpose of this guideline is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources....
Pulmonary Disease, Chronic Obstructive/diagnosis,
Pulmonary Disease, Chronic Obstructive/nursing,
Pulmonary Disease, Chronic Obstructive/complications,
Betacoronavirus,
Coronavirus Infections/complications,
Pneumonia, Viral/complications,
Pandemics/prevention & control
This clinical practice guideline provides evidence-informed recommendations for infection control, specimen collection, supportive care, pharmacological treatment, and prevention of complications.
The recommendations are directed to all health care staff who deal with patients in emergency departments an...
